These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31777257)

  • 1. Combined use of galectin-3 and thyroid peroxidase improves the differential diagnosis of thyroid tumors.
    Kalfert D; Ludvikova M; Kholova I; Ludvik J; Topolocan O; Plzak J
    Neoplasma; 2020 Jan; 67(1):164-170. PubMed ID: 31777257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined immunohistochemistry for thyroid peroxidase, galectin-3, CK19 and HBME-1 in differential diagnosis of thyroid tumors.
    Paunovic I; Isic T; Havelka M; Tatic S; Cvejic D; Savin S
    APMIS; 2012 May; 120(5):368-79. PubMed ID: 22515291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of CD15, galectin-3 and HBME-1 expression in follicular thyroid neoplasms].
    Bogdańska M; Górnicka B; Ziarkiewicz-Wróblewska B; Koperski L; Morton M; Wasiutyński A
    Endokrynol Pol; 2006; 57(4):314-9. PubMed ID: 17006830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expressions of RASSF1A, Galectin-3 and TPO mRNA in papillary thyroid carcinoma and their clinical significance].
    Xu MR; Chen Y; Zhou SR; Chi MM; Chen SL; Liu LY
    Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):356-60. PubMed ID: 19799084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of a combination of galectin-3 and thyroid peroxidase for the diagnosis and prognosis of thyroid cancer.
    Weber KB; Shroyer KR; Heinz DE; Nawaz S; Said MS; Haugen BR
    Am J Clin Pathol; 2004 Oct; 122(4):524-31. PubMed ID: 15487449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas.
    Nascimento MC; Bisi H; Alves VA; Longatto-Filho A; Kanamura CT; Medeiros-Neto G
    Endocr Pathol; 2001; 12(3):275-9. PubMed ID: 11740048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 and HBME-1 expression in oncocytic cell tumors of the thyroid.
    Volante M; Bozzalla-Cassione F; DePompa R; Saggiorato E; Bartolazzi A; Orlandi F; Papotti M
    Virchows Arch; 2004 Aug; 445(2):183-8. PubMed ID: 15252732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferative markers in diagnosis of thyroid tumors: a comparative study of MIB-1 and topoisomerase II-a immunostaining.
    Ludvíková M; Holubec L; Ryska A; Topolcan O
    Anticancer Res; 2005; 25(3A):1835-40. PubMed ID: 16033110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
    Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
    Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
    Saggiorato E; Aversa S; Deandreis D; Arecco F; Mussa A; Puligheddu B; Cappia S; Conticello S; Papotti M; Orlandi F
    J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-3 and Cyclin D3 Immunohistochemistry and Tumor Dimensions Are Useful in Distinguishing Follicular Oncocytic Carcinomas from Oncocytic Adenomas of the Thyroid.
    Cacchi C; Arnholdt HM; Haas CJ; Kretsinger H; Axt L; Märkl B
    Int J Endocrinol; 2015; 2015():276854. PubMed ID: 26604924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
    Abd-El Raouf SM; Ibrahim TR
    Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of CHEK1, SLC26A4, c-KIT, TPO and TG as new biomarkers for human follicular thyroid carcinoma.
    Makhlouf AM; Chitikova Z; Pusztaszeri M; Berczy M; Delucinge-Vivier C; Triponez F; Meyer P; Philippe J; Dibner C
    Oncotarget; 2016 Jul; 7(29):45776-45788. PubMed ID: 27329729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of thyroperoxidase mRNA splice variants in human thyroid tumors.
    Le Fourn V; Ferrand M; Franc JL
    Biochim Biophys Acta; 2004 Jun; 1689(2):134-41. PubMed ID: 15196594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine-needle aspiration of thyroid follicular neoplasm: diagnostic use of thyroid peroxidase immunocytochemistry with monoclonal antibody 47.
    De Micco C; Vasko V; Garcia S; Zoro P; Denizot A; Henry JF
    Surgery; 1994 Dec; 116(6):1031-5. PubMed ID: 7985083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of the thyroid peroxidase marker for distinguishing follicular thyroid carcinoma from follicular adenoma.
    Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
    Exp Oncol; 2006 Mar; 28(1):70-4. PubMed ID: 16614712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-3 expression in hyalinizing trabecular tumors of the thyroid gland.
    Gaffney RL; Carney JA; Sebo TJ; Erickson LA; Volante M; Papotti M; Lloyd RV
    Am J Surg Pathol; 2003 Apr; 27(4):494-8. PubMed ID: 12657934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potential.
    Papotti M; Rodriguez J; De Pompa R; Bartolazzi A; Rosai J
    Mod Pathol; 2005 Apr; 18(4):541-6. PubMed ID: 15529186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms.
    Inohara H; Honjo Y; Yoshii T; Akahani S; Yoshida J; Hattori K; Okamoto S; Sawada T; Raz A; Kubo T
    Cancer; 1999 Jun; 85(11):2475-84. PubMed ID: 10357421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-1 is a diagnostic marker involved in thyroid cancer progression.
    Arcolia V; Journe F; Wattier A; Leteurtre E; Renaud F; Gabius HJ; Remmelink M; Decaestecker C; Rodriguez A; Boutry S; Laurent S; Saussez S
    Int J Oncol; 2017 Sep; 51(3):760-770. PubMed ID: 28677745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.